Showing 13,641 - 13,660 results of 74,799 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (mean decrease)) ))', query time: 1.67s Refine Results
  1. 13641

    Table 1_Biomarkers for SARS-CoV-2 infection. A narrative review.docx by Sara Weronika Snopkowska Lesniak (20936051)

    Published 2025
    “…<p>COVID-19 is an infectious disease caused by SARS-CoV-2 with devastating effects on health-care systems. …”
  2. 13642
  3. 13643

    The shape of the exhalatory flow curve (Rpef) indicated changes following infection with SARS-CoV. by Vineet D. Menachery (761265)

    Published 2015
    “…(B) Following SARS-CoV infection of C57BL/6J animals, we identified significant differences in Rpef across a range of doses relative to mock animals (black = mock, blue = 10^3 SARS, green = 10^4, red = 10^5; four animals per group). …”
  4. 13644

    Five-year motor functional outcome in children with acquired brain injury. Yet to the end of the story? by Elena Beretta (4372495)

    Published 2017
    “…<p><i>Purpose</i>: The description of motor changes and clinical evolution of a pediatric cohort with acquired brain injury (ABI) over 5 years by the functional independence measure for children (WeeFIM). …”
  5. 13645

    GNB1 protein contributed to viral particle release triggered by H9N2 virus-derived M1 protein. by Fangtao Li (5730533)

    Published 2021
    “…Viral titers were measured by TCID<sub>50</sub> assay at the indicated time points. Each data is represented as means ± SD and represents three independent experiments. (**, <i>P</i> < 0.01; ***, <i>P</i> < 0.001; ns, no significance). …”
  6. 13646
  7. 13647

    Table_5_Pregnancy Complications and Outcomes Among Women With Congenital Heart Disease in Beijing, China.DOCX by Yang Liu (4829)

    Published 2022
    “…Objective<p>To conduct a comparative analysis of the complications and outcomes in pregnant women with and without congenital heart disease (CHD) in Beijing, China.</p>Methods<p>We compared pregnancy-related complications and outcomes experienced by women with and without CHD throughout 19,424 deliveries in Beijing Anzhen Hospital between 2010 and 2019, including cardiovascular and obstetric factors, fetal events, delivery methods, and other complications over a mean 5-years post-delivery follow-up period.…”
  8. 13648
  9. 13649
  10. 13650

    Data_Sheet_1_UGT1A1 Variants c.864+5G>T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays.PDF by Linda Gailite (8539332)

    Published 2020
    “…Crigler-Najjar syndrome (CNS) is characterized by a severe unconjugated hyperbilirubinemia caused by variants in the UGT1A1 gene. We previously reported one CNS-type II patient with two splice-site variants in trans (c.864+5G>T and c.996+2_996+5del). …”
  11. 13651
  12. 13652

    Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults by Prasad S. Kulkarni (12985371)

    Published 2024
    “…A decline in anti-S titers was observed in both vaccine groups, albeit with a greater decline in SII-ChAdOx1 nCoV-19 vaccinees (geometric mean titer [GMT] ratio [95% confidence interval (CI) of SII-ChAdOx1 nCoV-19 to AZD1222]: 0.60 [0.41–0.87]). …”
  13. 13653

    MicroRNA-296-5p is differentially expressed in individuals with and without HIV-1 infection by Jhonathan Cárdenas-Bedoya (10469493)

    Published 2021
    “…Thus, we measured the absolute expression of miR-296-5p by qPCR, confirming the result with statistically significant differences (P < 0.05). …”
  14. 13654

    ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency by Philippe Joly (3161052)

    Published 2017
    “…Finally, these findings support a larger scale screening for HERPUD1 R50H and HFE H63D variants in the sub-group of 1ATD patients developing significant chronic hepatic injuries (hepatomegaly, chronic cholestasis, elevated liver enzymes) and at risk developing liver cirrhosis.…”
  15. 13655
  16. 13656

    LRP5 Regulates Development of Lung Microvessels and Alveoli through the Angiopoietin-Tie2 Pathway by Tadanori Mammoto (72440)

    Published 2012
    “…Under physiological conditions when Ang1 is dominant, LRP5 knockdown decreases Tie2 expression and thereby, inhibits vascular and alveolar development in the lung. …”
  17. 13657

    Table5_Bioinformatics searching of diagnostic markers and immune infiltration in polycystic ovary syndrome.DOCX by Xinrui Yao (13540699)

    Published 2022
    “…This study aimed to identify potential diagnostic markers and explore the infiltration of immune cells in PCOS, contributing to the development of potential therapeutic drugs for this disease. We identified five key genes: CBLN1 (AUC = 0.924), DNAH5 (AUC = 0.867), HMOX1 (AUC = 0.971), SLC26A8 (AUC = 0,933), and LOC100507250 (AUC = 0.848) as diagnostic markers of PCOS. …”
  18. 13658
  19. 13659
  20. 13660